Overview

Pilot Study Of Pregabalin And Prediction Of Treatment Response In Patients With Postherpetic Neuralgia

Status:
Terminated
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The primary objective is to explore whether sensory symptom cluster analysis is useful for predicting treatment response in Postherpetic Neuralgia.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Treatments:
Pregabalin